{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:46Z","timestamp":1759048066174},"reference-count":15,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Liposomal amphotericin B was immunosuppressive on target cell lysis in vitro and on protection mediated by cytotoxic CD8 T cells in murine listeriosis. When dosages usually used for therapy in humans were compared, the immunosuppressive effect of 5 mg of liposomal amphotericin B\/kg of body weight\/day was similar to that of standard amphotericin B at 1 mg\/kg\/day, but a dosage of liposomal amphotericin B of 1 mg\/kg\/day was not suppressive in vivo.<\/jats:p>","DOI":"10.1128\/aac.45.8.2383-2385.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:55:30Z","timestamp":1027763730000},"page":"2383-2385","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Influence of Liposomal Amphotericin B on CD8 T-Cell Function"],"prefix":"10.1128","volume":"45","author":[{"given":"Marianne","family":"Kretschmar","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Institut fu\u0308r Medizinische Mikrobiologie und Hygiene,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Geginat","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institut fu\u0308r Medizinische Mikrobiologie und Hygiene,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Institut fu\u0308r Klinische Chemie,2 Fakulta\u0308t fu\u0308r Klinische Medizin Mannheim der Universita\u0308t Heidelberg, 68167 Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Walter","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institut fu\u0308r Medizinische Mikrobiologie und Hygiene,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Hof","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institut fu\u0308r Medizinische Mikrobiologie und Hygiene,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nichterlein","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institut fu\u0308r Medizinische Mikrobiologie und Hygiene,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.5.879"},{"key":"e_1_3_1_3_2","first-page":"585","article-title":"Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.","volume":"55","author":"Coukell A. J.","year":"1998","unstructured":"Coukell A. J. Brogden R. N. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs 55 1998 585 612","journal-title":"Drugs"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/514504"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/315007","article-title":"Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function.","volume":"180","author":"Geginat G.","year":"1999","unstructured":"Geginat G. Kretschmar M. Walter S. Junker D. Hof H. Nichterlein T. Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function. J. Infect. Dis. 180 1999 1186 1194","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.162.8.4781","article-title":"Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua.","volume":"162","author":"Geginat G.","year":"1999","unstructured":"Geginat G. Nichterlein T. Kretschmar M. Schenk S. Hof H. Lalic-Multhaler M. Goebel W. Bubert A. Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua. J. Immunol. 162 1999 4781 4789","journal-title":"J. Immunol."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.4049\/jimmunol.154.9.4642","article-title":"CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection.","volume":"154","author":"Harty J. T.","year":"1995","unstructured":"Harty J. T. Pamer E. G. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J. Immunol. 154 1995 4642 4650","journal-title":"J. Immunol."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/11.3.257","article-title":"Effect of amphotericin B on natural killer cell activity in vitro.","volume":"11","author":"Hauser W. E.","year":"1983","unstructured":"Hauser W. E. Jr. Remington J. S. Effect of amphotericin B on natural killer cell activity in vitro. J. Antimicrob. Chemother. 11 1983 257 262","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/clinids\/22.Supplement_2.S133","article-title":"Lipid formulations of amphotericin B: recent progress and future directions.","volume":"22","author":"Hiemenz J. W.","year":"1996","unstructured":"Hiemenz J. W. Walsh T. J. Lipid formulations of amphotericin B: recent progress and future directions. Clin. Infect. Dis. 22 (Suppl. 2) 1996 S133 144","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_10_2","first-page":"711","article-title":"Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.","volume":"46","author":"Kretschmar M.","year":"1996","unstructured":"Kretschmar M. Nichterlein T. Hannak D. Hof H. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis. Drug Res. 46 1996 711 715","journal-title":"Drug Res."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.47.2.429-433.1985"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.1997.tb00989.x","article-title":"Murine listeriosis as a model of antimicrobial defense.","volume":"158","author":"North R. J.","year":"1997","unstructured":"North R. J. Dunn P. L. Conlan J. W. Murine listeriosis as a model of antimicrobial defense. Immunol. Rev. 158 1997 27 36","journal-title":"Immunol. Rev."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/313749"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.12.2716"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/313756"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/514704","article-title":"Lipid formulations of amphotericin B: clinical efficacy and toxicities.","volume":"27","author":"Wong-Beringer A.","year":"1998","unstructured":"Wong-Beringer A. Jacobs R. A. Guglielmo B. J. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin. Infect. Dis. 27 1998 603 618","journal-title":"Clin. Infect. Dis."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.8.2383-2385.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.8.2383-2385.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T14:44:11Z","timestamp":1682261051000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.45.8.2383-2385.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1128\/AAC.45.8.2383-2385.2001"],"URL":"https:\/\/doi.org\/10.1128\/aac.45.8.2383-2385.2001","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2000-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}